Shareholder Information f) Restricted securities i) Unquoted securities There are no securities on issue subject to restriction agreements. As at the date of this report, the Company has unquoted securities as follows: There is currently no on-market buy back. Trading of the Company’s securities is available on the Australian Securities Exchange Limited (ASX : BLT) and through a Level 1 American Depositary Receipt (ADR) program in the Over-The-Counter (OTC : BTEBY) market in the United States. 2. On-Market Buy Back 3. Listing on Exchanges Details  Expiry Date  Exercise Price  Number Strategic Advisor warrants  4 August 2014  22.500  245,078  ESOP Options  19 August 2014  0.510  260,000  NED Options  19 August 2014  0.570  120,000  Unlisted Options - placement  18 February 2015  0.325  662,767  Unlisted other options  10 April 2015  2.500  480,000  Unlisted other options  23 October 2015  4.250  78,125  NED Options  26 September 2016  1.250  1,600,000  ESOP Options  17 November 2016  1.250  1,800,000  NED Options  26 September 2016  1.250  1,200,000  ESOP Options  7 February 2017  1.250  168,000  ESOP Options  18 July 2017  1.250  400,000  ESOP Options  16 November 2017  1.250   400,000  NED Options  18 May 2018  0.625  400,000  ESOP Options  22 August 2018  1.250  2,080,000  Unlisted options - placement  28 February 2019  1.260  13,246,203  ESOP Options  15 May 2019  1.500  180,000  23,320,173  Page 48 Benitec Biopharma Ltd  Annual Report 2014